| human | Q5 |
| P269 | IdRef ID | 057124388 |
| P496 | ORCID iD | 0000-0002-8215-2942 |
| P1153 | Scopus author ID | 7006318131 |
| P214 | VIAF ID | 208802271 |
| P69 | educated at | Paris Diderot University | Q1235608 |
| P108 | employer | French National Institute of Health and Medical Research | Q1474517 |
| P735 | given name | Bertrand | Q3637880 |
| Bertrand | Q3637880 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q28550755 | A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases |
| Q50910109 | A comparative study between carbohydrate-deficient transferrin and gamma-glutamyltransferase for the diagnosis of excessive drinking in a liver unit. |
| Q40496274 | A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients |
| Q42986521 | A rational attitude toward serum alanine aminotransferase measurement by blood banks, based on a longitudinal study of a cohort of repeat blood donors |
| Q42981580 | Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model |
| Q46628959 | Alcohol problems in drinking drivers and clinical management methods |
| Q53460729 | Alcohol, hepatotropic viruses, and hepatocellular carcinoma. |
| Q53021746 | Analytical evaluation of a new capillary electrophoresis method for carbohydrate-deficient transferrin measurement. |
| Q33980963 | Argentine tango: Another behavioral addiction? |
| Q62658401 | Assessment of the Transferrin Index in Screening Heavy Drinkers from a General Practice |
| Q62658393 | Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease |
| Q46454767 | Automated measurement of carbohydrate-deficient transferrin using the Bio-Rad %CDT by the HPLC test on a Variant HPLC system: evaluation and comparison with other routine procedures. |
| Q41925341 | BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease |
| Q35438948 | Brief report: genetics of alcoholic cirrhosis-GenomALC multinational study |
| Q35598120 | Changes to hepatocyte ploidy and binuclearity profiles during human chronic viral hepatitis |
| Q41108998 | Chronic alcohol intoxication decreases the serum level of hepatitis B surface antigen in transgenic mice. |
| Q34538514 | Clinical management methods for out-patients with alcohol dependence |
| Q42998790 | Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C. |
| Q92617162 | Comparison of e-cigarette use characteristics between exclusive e-cigarette users and dual e-cigarette and conventional cigarette users: an on-line survey in France |
| Q53821183 | Comparison of the MoCA and BEARNI tests for detection of cognitive impairment in in-patients with alcohol use disorders. |
| Q62658368 | DETECTION OF CIRCULATING PROSTATE DERIVED CELLS IN PATIENTS WITH PROSTATE ADENOCARCINOMA IS AN INDEPENDENT RISK FACTOR FOR TUMOR RECURRENCE |
| Q73754223 | Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence |
| Q48334678 | Determination of MoCA Cutoff Score in Patients with Alcohol Use Disorders. |
| Q62658390 | Dexamethasone for Alcohol Withdrawal |
| Q45421359 | Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus |
| Q57782779 | Direct and indirect evidence for the reversibility of cirrhosis |
| Q42988588 | ESBRA 1997 Award lecture: relationship between excessive alcohol drinking and viral infections. |
| Q62658366 | Effect of pregnancy on chronic hepatitis C: a case-control study |
| Q41322174 | Effects of ethanol on hepatitis B virus Pre-S/S gene expression in the human hepatocellular carcinoma derived HEP G2 hepatitis B DNA positive cell line |
| Q62658381 | Effects of interleukin-2 on hepatitis B vaccination in uraemic patients |
| Q62658364 | Efficacy and limitations of a specific immunotherapy in chronic hepatitis B |
| Q46797344 | Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency |
| Q56234996 | Ethanol Effects in a Rat Hepatoma Cell Line: Induction of γ -Glutamytransferase |
| Q62658402 | Evaluation of mAST/tAST ratio as a marker of alcohol misuse in a non-selected population |
| Q45800369 | Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. |
| Q44849257 | Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease |
| Q62658359 | FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest |
| Q52303011 | Feasibility and Efficacy of an Addiction Treatment Program in Patients With Upper Aerodigestive Tract Cancer. |
| Q40432273 | Follow-Up of Alcohol Consumption After Liver Transplantation: Interest of an Addiction Team? |
| Q46705623 | French National Research Program on alcohol |
| Q29417113 | Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection |
| Q43039277 | HCV infection in alcoholics. |
| Q62658413 | HEPATITIS B VACCINATION AND ALCOHOLIC CIRRHOSIS |
| Q62658397 | Hepatic activity and mRNA expression of aspartate aminotransferase isoenzymes in alcoholic and nonalcoholic liver disease |
| Q62658404 | Hepatitis B vaccination in chronic alcoholics |
| Q36475587 | Hepatitis C infection in alcoholics |
| Q42983259 | Hepatitis C viremia and anti-HCV antibodies in alcoholics |
| Q43039139 | Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels. |
| Q43040410 | Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group |
| Q43034463 | Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C. |
| Q40539996 | Hepatocellular carcinoma in alcoholics. |
| Q42987744 | Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C. |
| Q43047523 | IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes |
| Q91368034 | Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing |
| Q47865691 | Immunotherapy of chronic hepatitis B by anti HBV vaccine. |
| Q41741892 | Impact of common risk factors of fibrosis progression in chronic hepatitis C. |
| Q48003450 | Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer |
| Q43753038 | Impact of medical recommendations on alcohol consumption in HCV positive patients. |
| Q44775951 | Impact of tobacco and alcohol consumption in patients registered on waiting list on early morbidity following liver transplantation |
| Q62658375 | Improvement of the CD4 cell count after alcohol withdrawal in HIV-positive alcoholic patients |
| Q42983598 | Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C. |
| Q46487321 | Influence of liver biopsy on abstinence in alcohol-dependent patients |
| Q40937852 | Interactions between alcohol and hepatitis viruses in the liver. |
| Q45867534 | Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. |
| Q44703198 | Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection |
| Q48125573 | Intervention study to improve smoking cessation during hospitalization |
| Q33199822 | Intrahepatic hepatitis C virus RNA quantification in microdissected hepatocytes |
| Q37504092 | Investigation of Cognitive Improvement in Alcohol-Dependent Inpatients Using the Montreal Cognitive Assessment (MoCA) Score |
| Q45740568 | Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy? |
| Q62658399 | Liver collagen mRNA and serum amino-terminal peptide of type III procollagen (PIIINP) levels in patients with alcoholic liver disease |
| Q50222816 | Maintenance of Abstinence in Self-Help Groups |
| Q45352065 | Management of hepatitis C virus infection in heavy drinkers |
| Q45756347 | Medical practices regarding hepatitis C virus infection in Europe |
| Q50737231 | MoCA as a Screening Tool of Neuropsychological Deficits in Alcohol-Dependent Patients. |
| Q45215557 | Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake |
| Q44844126 | Monoclonal anti-HBs antibodies radioimmunoassay and serum HBV-DNA hybridization as diagnostic tools of HBV infection: relative prevalence among HBsAg-negative alcoholics, patients with chronic hepatitis or hepatocellular carcinomas and blood donors |
| Q42984088 | Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. |
| Q62658388 | Nested polymerase chain reaction on cellular DNA in plasma: a rapid method to investigate the collagen type I A2 MspI polymorphic restriction site in alcoholic patients |
| Q45364849 | Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients. |
| Q28292946 | Nucleotide sequence and tissue distribution of the human mitochondrial aspartate aminotransferase mRNA |
| Q62658383 | PGA score In diagnosis of alcoholic fibrosis |
| Q62658378 | Pathogenetic relevance of LKM-3 autoantibodies in chronic hepatitis D |
| Q27489097 | Pathological evolution of hepatitis C virus-“Healthy carriers” |
| Q52297964 | Pathological gambling in treatment-seeking alcoholics: a national survey in France. |
| Q62658386 | Persistence of Hepatitis B and Hepatitis C Viral Genomes in Primary Liver Cancers from HBsAg-Negative Patients: A Study of a Low-endemic Area |
| Q34296276 | Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? |
| Q62658409 | Plasma Lipoprotein and Apolipoprotein Profile in Alcoholic Patients with and without Liver Disease: On the Relative Roles of Alcohol and Liver Injury |
| Q45849086 | Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen |
| Q45351873 | Polymorphism of alcohol dehydrogenase, alcohol and aldehyde dehydrogenase activities: implication in alcoholic cirrhosis in white patients. The French Group for Research on Alcohol and Liver |
| Q50871419 | Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. |
| Q47724528 | Prevalence of Psychoactive Substance Consumption in People With Obesity |
| Q45389835 | Prognosis assessment of alcoholic liver disease: how and why? |
| Q41310208 | Protein assay by immunoprecipitation with Centrifichem centrifugal analyser |
| Q62658357 | Prothrombin index slope is an early prognostic marker in patients with severe acute liver diseases: Figure 1 |
| Q52300468 | Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. |
| Q62658392 | Recovery from disturbed colonic transit time after alcohol withdrawal |
| Q42989119 | Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. |
| Q42982733 | Reversibility of hepatitis C virus-related cirrhosis |
| Q45773254 | Secondary immune response to hepatitis B virus vaccine in alcoholics. |
| Q62658410 | Serum Activity of Mitochondrial Aspartate Aminotransferase: A Sensitive Marker of Alcoholism With or Without Alcoholic Hepatitis |
| Q43037527 | Serum hepatitis C virus (HCV) RNA: a reliable tool for evaluating HCV-related liver disease in anti-HCV-positive blood donors with persistently normal alanine aminotransferase values |
| Q62658407 | Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: Diagnostic value and interpretation in a liver unit |
| Q62658377 | Serum secretory IgA and secretory component in patients with non-cirrhotic alcoholic liver diseases |
| Q42994265 | Significance of repeatedly normal aminotransferase activities in HCV-infected patients |
| Q45756845 | Significance of repeatedly normal aminotransferase activities in hepatitis C virus-infected patients |
| Q62658380 | Specific vaccine therapy in chronic hepatitis B infection |
| Q62658373 | Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer |
| Q62658412 | Spur cells in patients with alcoholic liver cirrhosis are associated with reduced plasma levels of apoA-II, HDL3, and LDL |
| Q92055466 | Sugar intake and craving during alcohol withdrawal in alcohol use disorder inpatients |
| Q45354052 | T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines/chemokines in chronic hepatitis B patients. ANRS study: HB EP 02 HBSP-FIBRO. |
| Q45729149 | The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis |
| Q44815654 | The prevalence of optic neuropathy in alcoholic patients--a pilot study |
| Q62658370 | Triggering of acute alcoholic hepatitis by α-interferon therapy |
| Q50748480 | Use of Psychoactive Medication in Short- and Long-term Abstainers from Alcohol. |
| Q35851043 | Variation in AUDIT (Alcohol Use [correction of Used] Disorder Identification Test) scores within the first weeks of imprisonment |
Search more.